0337B |
Amphetamines Screen, Blood |
0337FL |
Amphetamines Screen, Fluid |
0337SP |
Amphetamines Screen, Serum/Plasma |
0337U |
Amphetamines Screen, Urine |
0610B |
Benzphetamine as Metabolites, Blood |
0610SP |
Benzphetamine as Metabolites, Serum/Plasma |
0610U |
Benzphetamine as Metabolites, Urine |
1864ME |
Drugs of Abuse Screen (10 Panel), Meconium |
2800B |
Lisdexamfetamine as Metabolite, Blood |
2800SP |
Lisdexamfetamine as Metabolite, Serum/Plasma |
2800U |
Lisdexamfetamine as Metabolite, Urine |
6904ME |
Drugs of Abuse Screen (7 Panel), Meconium |
6924H |
Amphetamines Screen, Hair |
8600B |
Amphetamines Panel, Blood |
8600FL |
Amphetamines Panel, Fluid |
8600ME |
Amphetamines Panel (Qualitative), Meconium |
8600SP |
Amphetamines Panel, Serum/Plasma |
8600TI |
Amphetamines Panel, Tissue |
8600U |
Amphetamines Panel, Urine |
8890OF |
Amphetamines Panel (Qualitative), Oral Fluid (Saliva) |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9351UC |
Basic Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9352UC |
Expanded Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |